25 May 2013
Keywords: zosano, complete, end-of-ph, ii, zp-pth, meeting, fda
Article | 15 December 2008
Texas, USA-based Zosano Pharma, a privately-held firm developing products using a novel transdermal delivery technology, says that it has
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 December 2008
24 May 2013
© 2013 thepharmaletter.com